Chronic intestinal pseudo-obstruction

Best Practice and Research in Clinical Gastroenterology

Volumn 21, Issue 4, 2007, Pages 657-669

  Cogliandro, Rosanna F ^a   De Giorgio, Roberto ^a   Barbara, Giovanni ^a   Cogliandro, Laura ^a   Concordia, Alessandra ^a   Corinaldesi, Roberto ^a   Stanghellini, Vincenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

intestinal pseudo obstruction; intestinal transplantation; prokinetics; small bowel manometry; small bowel motility

Indexed keywords

ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; LAXATIVE; LEUPRORELIN; LIDOCAINE; METOCLOPRAMIDE; METRONIDAZOLE; NORADRENALIN; OCTREOTIDE; OPIATE; PAROMOMYCIN; PETHIDINE; PROKINETIC AGENT; PROSTAGLANDIN; RIFAXIMIN; SEROTONIN; SOMATOSTATIN; SPASMOLYTIC AGENT; STEROID; STOMACH SECRETION INHIBITOR; TEGASEROD; TETRACYCLINE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG USE; ELECTROSTIMULATION THERAPY; FAMILIAL DISEASE; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL CELL OF CAJAL; INTESTINE FUNCTION DISORDER; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; INTESTINE PSEUDOOBSTRUCTION; INTESTINE SURGERY; MNGIE SYNDROME; MYOPATHY; NEUROPATHY; NUTRITIONAL SUPPORT; OUTCOMES RESEARCH; PATHOGENESIS; SIDE EFFECT; SMOOTH MUSCLE FIBER; TACHYPHYLAXIS; THROMBOCYTE TRANSFUSION;

CHRONIC DISEASE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION;

EID: 34447515450     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.03.002     Document Type: Article

References (67)

1. Stanghellini V., Corinaldesi R., and Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 2 (1988) 225-254
2. Stanghellini V., Cogliandro R.F., De Giorgio R., et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroent Hepatol 3 (2005) 449-458
3. Stanghellini V., Camilleri M., and Malagelada J.R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 28 (1987) 5-12
4. De Giorgio R., and Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 16 (2004) 515-531
5. De Giorgio R., Sarnelli G., Corinaldesi R., et al. Advance in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 53 (2004) 1549-1552
6. De Giorgio R., Seri M., Cogliandro R., et al. Analysis of candidate genes for intrinsic neuropathy in a family with chronic idiopathic intestinal pseudo-obstruction. Clin Gen 59 (2001) 131-133
7. Deglincerti A, De Giorgio R, Cefle K, et al. Homozygosity mapping of an autosomal recessive syndromic chronic idiopathic intestinal pseudo-obstruction. Eur J Human Gen 2007, in press.
8. Finsterer J. Mitochondriopathies. Eur J Neurol 11 (2004) 163-186
9. Hirano M., Silvestri G., Blake D., et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44 (1994) 721-727
10. Nishino I., Spinazzola A., Papadimitriou A., et al. Mitochondrial neurogastrointestinal encephalopathy: an autosomal recessive disorder due to thymidine phosphorylase mutastions. Ann Neurol 47 (2000) 792-800
11. Gillis L., and Kaye E. Diagnosis and management of mitochondrial disease. Pediatr Clin N Am 49 (2002) 203-219
12. Nishino I., Spinazzola A., and Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 (1999) 689-692
13. Martì R., Spinazzola A., Tadesse S., et al. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 50 (2004) 120-124
14. Spinazzola A., Martì R., Nishino I., et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277 (2002) 4128-4133
15. Martì R., Nishigaki Y., and Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 303 (2003) 14-18
16. De Giorgio R., Guerrini S., Barbara G., et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126 (2004) 1872-1883
17. Smith V.V., Gregson N., Foggensteiner L., et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 112 (1997) 1366-1367
18. De Giorgio R., Barbara G., Stanghellini V., et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 97 (2002) 2454-2459
19. King P.H., Redden D., Palmgren J.S., et al. Hu antigen specificities of ANNA-1 autoantibodies in paraneoplastic neurological disease. J Autoimmun 13 (1999) 435-443
20. De Giorgio R., Guerrini S., Barbara G., et al. New insights into human enteric neuropathies. Neurogastroenterol Motil 16 Suppl 1 (2004) 143-147
21. Krishnamurthy S., and Schuffler M.D. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 93 (1987) 610-639
22. Hockenbery D., Nunez G., Milliman C., et al. Bcl-2 is a inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
23. De Giorgio R., Barbara G., Stanghellini V., et al. Reduced Bcl-2 expression in the enteric nervous system as a marker for neuronal degeneration in patients with gastrointestinal motor disorders. Gastroenterology 118 (2000) A867
24. Ruhl A. Glial cells in the gut. Neurogastroenterol Motil 17 (2005) 777-790
25. Isozaki K., Hirota S., Miyagawa J.-I., et al. Deficiency of c-Kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol 92 (1997) 332-334
26. Feldstein A.E., Miller S.M., El-Youssef M., et al. Chronic intestinal pseudo-obstruction associated with altered interstitial cells of Cajal network. J Pediatr Gastroenterol Nutr 36 (2003) 492-497
27. Huizinga J.D., Thuneberg L., Vanderwinden J.M., et al. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders. Trends Pharmacol Sci 18 (1997) 393-403
28. Sanders K.M., Ordog T., and Ward S.M. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to beside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. Am J Physiol 282 (2002) G747-G756
29. Boeckxstaens G.E., Rumessen J.J., de Wit L., et al. Abnormal distribution of interstitial cells of Cajal in an adult patient with pseudo-obstruction and megaduodenum. Am J Gastroenterol 97 (2002) 2120-2126
30. Malagelada J.R., and Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 88 (1985) 1223-1231
31. Attar A., Kuoch V., Ducreux M., et al. Simultaneous decompression colonoscopy and radiologic G-tube insertion in a patient with megacolon because of chronic colonic pseudo-obstruction. Gastrointest Endosc 62 (2005) 975-976
32. Fell J.M.E., Smith V.V., and Milla P.J. Infantile chronic idiopathic intestinal pseudo-obstruction: the role of small intestinal manometry as a diagnostic tool and prognostic indicator. Gut 39 (1996) 306-311
33. Kellow J.E. Small intestine: normal function and clinical disorders. Manometry. In: Schuster M.M., Crowell M.D., and Koch K.L. (Eds). Schuster atlas of gastrointestinal motility in health and disease (2002), BC Decker, Hamilton-London 219-236
34. Cogliandro R., Stanghellini V., Cogliandro L., et al. Small bowel manometric findings in different forms of severe digestive syndromes. Neurogastroenterol Motil 16 (2004) A838
35. Camilleri M., Stanghellini V., and Azpiroz F. Small bowel manometry. Dig Dis Sci 42 (1997) 2401-2402
36. Hyman P.E., McDiarmid S.V., Napolitano J., et al. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 112 (1988) 899-905
37. Hyman P.E., Di Lorenzo C., McAdams L., et al. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 88 (1993) 832-836
38. Boige N., Faure C., Cargill G., et al. Manometrical evaluation in visceral neuropathies in children. J Pediatr Gastroenterol Nutr 19 (1994) 71-77
39. Cucchiara S., Annese V., Minella R., et al. Antroduodenojejunal manometry in the diagnosis of chronic idiopathic intestinal pseudoobstruction in children. J Pediatr Gastroenterol Nutr 18 (1994) 294-305
40. Di Lorenzo C., Flores A.F., Buie T., et al. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 108 (1995) 1379-1385
41. Heneyke S., Smith V.V., Spitz L., et al. Chronic intestinal pseudo-obstruction: treatment and long-term follow-up of 44 patients. Arch Dis Child 81 (1999) 21-27
42. Mousa H., Hyman P.E., Cocjin J., et al. Long-term outcome of congenital intestinal pseudo-obstruction. Dig Dis Sci 47 (2002) 2298-2305
43. Knowles C.H., Silk D.B.A., Darzi A., et al. Deranged smooth muscle alpha-actin: a bio-marker of intestinal pseudo-obstruction. A controlled multinational case series. Gut 53 (2004) 1583-1589
44. Mann S.D., Debinski H.S., and Kamm M.A. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 41 (1997) 675-681
45. Faure C., Goulet O., Ategbo S., et al. Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome and prognosis in 105 children. Dig Dis Sci 44 (1999) 953-959
46. Camilleri M., Balm R.K., and Zinsmeister A.R. Determinant of response to a prokinetic agent in neuropathic chronic intestinal motility disorders. Gastroenterology 106 (1994) 916-923
47. Verne G., Eaker E., Hardy E., et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 40 (1995) 1892-1901
48. Cogliandro R., Stanghellini V., Cogliandro L., et al. Symptomatic response to short-term treatment with cisapride but not small bowel manometry predicts a positive outcome in adult patients with chronic idiopathic intestinal pseudo-obstruction (CIIP). Gastroenterology 116 (1999) A1087
49. Emmanuel A.V., Shand A.G., and Kamm M.A. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 19 (2004) 687-694
50. Stanghellini V., Corinaldesi R., Ghidini C., et al. Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. Hepatogastroenterology 39 (1992) 34-38
51. Pironi L., Spinucci G., Paganelli F., et al. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. Transplant Proc 36 (2004) 659-661
52. Gugliemi F.W., Boggio-Bertinet D., Federico A., et al. Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 38 (2006) 623-642
53. Barbara G., Stanghellini V., Brandi G., et al. Interactions between commensal bacteria and gut sensory motor function in health and disease. Am J Gastroenterol 100 (2005) 2560-2568
54. Camilleri M., Malagelada J.R., Abell T.L., et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 96 (1989) 704-712
55. Di Lorenzo C., Reddy S.N., Villanueva-Meyer J., et al. Cisapride in children with chronic intestinal pseudo-obstruction. An acute, double blind, crossover, placebo controlled trial. Gastroenterology (1991) 1564-1570
56. Abell T.L., Camilleri M., Dimagno E.P., et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36 (1991) 616-620
57. Soudah H.C., Hasler W.L., and Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 325 (1991) 1461-1467
58. Camilleri M., Balm R.K., and Zinsmeister A.R. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic dysmotility. Aliment Pharmacol Ther 10 (1996) 403-409
59. Pasha S.F., Lunsford T.N., and Lennon V.A. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 131 (2006) 1592-1596
60. Lyford G., and Foxx-Orenstein A. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 7 (2004) 317-325
61. Zimmerman D.M., Gidda J.S., Cantrell B.E., et al. Discovery of a potent, peripherally selective trans-3-4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders. J Med Chem 37 (1994) 2262-2265
62. Wolff B.G., Michelassi F., Gerkin T.M., et al. Alvimopan a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and post-operative ileus. Ann Surg 240 (2004) 728-734
63. Andersson S., Lonroth H., Simren M., et al. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction. Neurogastroenterol Motil 18 (2006) 823-830
64. Lara M.C., Weiss B., Illa I., et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67 (2006) 1461-1463
65. Murr M., Sarr M., and Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudo-obstruction. Am J Gastroent 90 (1995) 2147-2151
66. Kim H.Y., Kim J.H., Jung S.E., et al. Surgical treatment and prognosis of chronic intestinal pseudo-obstruction in children. J Pediatric Surg 40 (2005) 1753-1759
67. Masetti M., Di Benedetto F., Cautero N., et al. Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients. Am J Transplantation 4 (2004) 826-829